In the current issue of Vanity Fair, with Johnny Depp on the cover, investigative journalists Donald L. Barlett and James B. Steele take on a scandal one doesn't expect among the Conde Nast magazine's usual Hollywood profiles and tales of hedge-fund managers' profligacy. In their article, "Deadly Medicine," the two explore the world of outsourcing drug safety and efficacy testing overseas, and ask the crucial question of what the increasingly common practice is doing to the quality and safety of American prescription drugs. The article is a scathing indictment of the pharmaceutical industry practice, which has seen overseas drug testing skyrocket from 271 trials in 1990 to 6,485 in 2008 according to the authors. It comes on the heals of a recent lawsuit over "potential fraud and scientific misconduct" allegedly committed during trials of a much-anticipated new insulin inhaler tested by the American biotech firm, Mannkind, in Russia and Bulgaria. Reading the in-depth investigation feels like looking at the tip of the iceberg.

Read more about the article at iwellville.com.

Recent Posts in The Source of Healing

What Can Pose a Greater Cancer Risk than Smoking?

Deeply troubling evidence on the dangers of sleeping pills.

The Long Lasting Effects of Negative Information

Just one occasion of negative information can induce long-lasting effects.

A Fight for More Scrutiny: The First GMO Animal Built for Human Consumption

Is the first genetically engineered animal about to land on your dinner plate?

Food Safety Czar's Fuel Farms

Just one fuel-corn kernel could wreak havoc.

Vanity Fair Exposes Pharmaceutical Industry

The article is a scathing indictment of a pharmaceutical industry practice.